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Granulocytes promote lung graft injury in Bcl3-deficient recipients. (A) Assessment of PaO2 (left) and exclusion of EBD (right) 6 and 24 hours 
following B6 → B6 (B6) or B6 → B6 (Bcl3–/–) lung engraftment. (B and C) Representative graft histology (original magnification, ×100) (n = 11) 
(B) and intragraft MPO activity (C) 24 hours following B6 → B6 (B6) or B6 → B6 (Bcl3–/–) lung engraftment. (D) Left: Representative FACS 
analysis (n = 5). Numbers denote percent abundance of granulocytes in graft tissue. Right: Granulocyte counts in BAL at 6 and 24 hours follow-
ing B6 → B6 (B6) or B6 → B6 (Bcl3–/–) lung engraftment. (E) Left: B6 → B6 (Bcl3–/–) lung recipients were partially depleted for granulocytes with 
Ly6G-specific antibodies or treated with control Ig 4 hours prior to transplantation and assessed for percent abundance of granulocytes in graft 
tissue 24 hours after engraftment. Right: Granulocyte counts at 6 and 24 hours following engraftment in BAL. (F) Assessment of PaO2 (left) and 
EBD exclusion (right) at 6 and 24 hours following engraftment. (G) Representative lung graft histology (original magnification, ×100) of B6 → B6 
(Bcl3–/–) recipients 24 hours after engraftment following treatment with either control Ig or Ly6G-specific antibodies (n = 4). Data are mean ± SD 
and, unless otherwise indicated, represent at least 3 independent experiments. *P < 0.05; **P < 0.01.
research article















































































































Neutrophils (103/μl) 1.15 ± 0.18 1.32 ± 0.44
Lymphocytes (103/μl) 5.93 ± 1.27 6.79 ± 0.82
Monocytes (103/μl) 0.19 ± 0.10 0.27 ± 0.14
Eosinophils (103/μl) 0.15 ± 0.01 0.17 ± 0.02
Basophils (103/μl) 0.27 ± 0.02 0.34 ± 0.09
Differential counts. Peripheral blood analysis of B6 (B6) and B6 (Bcl3–/–) 
mice. n = 7/group. All values are P ≥ 0.17 for B6 (B6) versus B6 (Bcl3–/–).
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Functional and phenotypic assessment of B6 and Bcl3-deficient granulocytes. (A) Assessment of granulocyte recruitment into lung grafts. 
CFSE-labeled B6 or Bcl3–/– granulocytes (5 × 106) were assessed by FACS analysis in B6 → B6 lung grafts 3 hours following adoptive transfer. 
Numbers denote percent abundance of CFSE-labeled granulocytes within grafts. Results are representative of 3 independent experiments. 
(B) Nuclear morphology (original magnification, ×400) of B6 or Bcl3–/– granulocytes following Wright Giemsa stain. (C) Evaluation of granulocyte 
activation measured by CD11b and CD62L expression on granulocytes before (left) or 18 hours after (right) B6 → B6 (B6) or B6 → B6 (Bcl3–/–) 
lung engraftment. Results are representative of 5 independent experiments. (D) Measurement of f-MLP– or PMA-mediated ROS generation 
from bone marrow–derived or BAL-derived B6 or Bcl3–/– granulocytes 24 hours after engraftment. Data are representative of 3 independent 
experiments. (E) Survival in vivo of BAL granulocytes from B6 → B6 (Bcl3–/–) or B6 → B6 (B6) lung recipients 24 hours following transplanta-
tion depicted as a representative FACS plot (n = 6) (left) or as a scatter plot (right) showing percent abundance of Annexin V+ granulocytes. 
Data are representative of 7 independent experiments. (F) Survival ex vivo of B6 or Bcl3–/– granulocytes in the absence or presence of G-CSF 
(10 ng/ml) shown normalized to the number of Annexin V– cells at the initiation of culture. Data are representative of 2 independent experiments. 
Data represent mean ± SD. *P < 0.05.
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Bcl3 limits G-CSF–mediated emergency 
granulopoiesis. (A) Left: Representative 
FACS analysis (n = 3). Numbers denote 
percent abundance of peripheral blood 
granulocytes at 24 hours following B6 → B6 
(Bcl3–/–) or B6 → B6 (B6) lung engraftment. 
Right: Peripheral blood granulocyte num-
bers for indicated time points up to 72 hours 
after B6 → B6 (Bcl3–/–) or B6 → B6 (B6) 
lung transplantation (n = 4). (B) Represen-
tative FACS analysis (n = 3) of MPO+Gr1+ 
populations in the bone marrow of B6 (B6) 
or B6 (Bcl3–/–) mice 18 hours following the 
implantation of B6 lungs. Numbers indicate 
percent abundance of the indicated popu-
lations within the bone marrow. (C) Serum 
concentrations of indicated cytokines fol-
lowing B6 → B6 (Bcl3–/–) or B6 → B6 (B6) 
lung engraftment (n = 4). (D) Peripheral 
blood granulocyte numbers 24 hours fol-
lowing intravenous administration of 5 μg of 
G-CSF, GM-CSF, or IL-3 to either B6 (B6) 
or B6 (Bcl3–/–) mice (n = 5). Data represent 
mean ± SD. *P < 0.05; **P < 0.01.
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Figure 4
Proliferation and differentiation of Bcl3-deficient myeloid progenitors. (A) Left: Methylcellulose colony count from B6 or Bcl3–/– bone mar-
row cells cultured with indicated cytokines. Right: Number of cells per colony. Data are representative of 2 independent experiments. (B) 
Representative FACS analysis (n = 4) of MPO expression in liquid CMP cultures following 18 hours of stimulation with indicated cytokines. 
Numbers within histograms indicate percent abundance of MPO+ cells. (C) Granulocyte output from CMP liquid cultures following 72 hours 
of stimulation with indicated cytokines. (D) Indicated transcript accumulation in peripheral blood granulocytes isolated from B6 (B6) or B6 
(Bcl3–/–) mice 24 hours following a 5-μg injection of G-CSF. (E) Indicated transcript accumulation in CMPs isolated from B6 (B6) or B6 (Bcl3–/–) 
mice 24 hours following injection of 5 μg of indicated cytokines. (F) Bottom: CMP BrdU incorporation in response to indicated concentrations 
of G-CSF, GM-CSF, or IL-3 following 18 hours of liquid culture. Data are representative of at least 3 independent experiments. Top: Cyclin 
D3 transcript accumulation in CMPs isolated from B6 (B6) or B6 (Bcl3–/–) mice 24 hours following injection of 5 μg of indicated cytokines. 
(G) Representative (n = 3) BrdU incorporation of bone marrow Lin–Sca-1–c-Kit+ cells (GMPs; CD34+CD16/32+) and (CMPs; CD34+CD16/32–) 
in B6 →B6 (B6) or B6 (Bcl3–/–) lung recipients 24 hours following transplantation. Dot plot numbers indicate percent abundance. Data rep-
resent mean ± SD. *P < 0.05; **P < 0.01.
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The dynamics and effects of Bcl3 expression in myeloid progenitors. (A) Representative (n = 4) Bcl3 transcript expression in B6 myeloid progeni-
tors or granulocytes (Gran) before (control) and after 18 hours of stimulation with 10 ng/ml of indicated cytokines in liquid culture. (B) Representa-
tive (n = 4) Bcl3 transcript level expression in myeloid progenitors and granulocytes purified from resting B6 mice, B6 → B6 (B6) treated with con-
trol Ig or G-CSF–specific antibodies 18 hours following transplantation. (C) Representative (n = 2) Bcl3 transcript accumulation in G-CSFRΔ715F 
myeloid cell progenitors. (D) Representative (n = 2) analysis of STAT3 association with Bcl3 promoter. Lin– B6 bone marrow cells were stimulated 
with indicated cytokines. Chromatin immunoprecipitation was then conducted with STAT3-specific or control antibodies, and amplification was 
performed with primers specific for an enhancer region of Bcl3. (E) Assessment of Bcl3 ectopic expression on NF-κB p50 protein accumulation. 
Lin– B6 bone marrow cells were transfected with MSCV, MSCV-Bcl3 (encoding N-FLAG Bcl3), or MSCV NF-κB p50 (encoding N-FLAG NF-κB 
p50). Nuclear protein was extracted, immunoblotted, and probed with FLAG–, NF-κB p50–, Oct-1–, and β-actin–specific antibodies. Results are 
representative of 3 independent experiments. (F) Top: Representative FACS analysis (n = 5). Numbers denote percent abundance of granulo-
cytes in Lin– bone marrow cell cultures following 3 days of stimulation with indicated cytokines. Bottom: Mean percent abundance of granulocytes 
calculated from 5 independently conducted cultures derived from data in top panel. Data represent mean ± SD. *P < 0.05; **P < 0.01.
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G-CSF blockade prevents graft injury in B6 (Bcl3–/–) lung recipients. (A) Granulocyte numbers in the peripheral blood (left) and BAL (middle) at 6 
and 24 hours post-engraftment and a representative FACS analysis (24 hours; right) in which numbers indicate granulocyte percent abundance 
in graft tissue in B6 → B6 (Bcl3–/–) lung recipients treated with control Ig or G-CSF–specific antibodies (n = 10). (B) PaO2 (left) and EBD exclusion 
(middle) 6 and 24 hours post-engraftment and representative graft histology (right; original magnification, ×100) in B6 → B6 (Bcl3–/–) lung graft 
recipients 24 hours after engraftment treated with control Ig or G-CSF–specific antibodies (n = 10). Data represent mean ± SD. *P < 0.05.
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DC. Impaired production and increased apopto-
sis of neutrophils  in granulocyte colony-stimu-
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